Patents Assigned to Elektrofi, Inc.
  • Patent number: 11717488
    Abstract: The present disclosure relates to compositions and methods that enable the formation of pharmaceutically relevant particles that can be used for therapy. In particular, the methods disclosed herein allow the controlled formation of circular particles having low internal void spaces comprising bioactive therapeutic agents.
    Type: Grant
    Filed: June 18, 2021
    Date of Patent: August 8, 2023
    Assignee: Elektrofi, Inc.
    Inventors: Paul Brown, Lyndon Fitzgerald Charles, Jr., Chase Spenser Coffman, Daniel Benjamin Dadon, James Ivey, Lisa Liu, Chaitanya Sudrik
  • Patent number: 11654112
    Abstract: The invention provides particles, compositions including the particles, and methods of making the particles using electrospray. In certain embodiments, the particles allow for high concentrations of a therapeutic or diagnostic agent to be delivered at low viscosity. Particles may also exhibit beneficial properties with respect to stability.
    Type: Grant
    Filed: November 22, 2017
    Date of Patent: May 23, 2023
    Assignee: Elektrofi, Inc.
    Inventors: Chase Coffman, Lyndon Charles, Paul Brown, Daniel Benjamin Dadon, Lisa Liu, Cory Robinson
  • Patent number: 11459376
    Abstract: The present disclosure provides compositions and methods for treating a disease or condition in a subject in need thereof, comprising administering to the subject a pharmaceutically effective amount of a composition comprising a plurality of particles comprising at least one therapeutic biologic suspended in a pharmaceutically acceptable liquid carrier.
    Type: Grant
    Filed: June 18, 2021
    Date of Patent: October 4, 2022
    Assignee: Elektrofi, Inc.
    Inventors: Paul Brown, Tyler L. Carter, Lyndon Fitzgerald Charles, Jr., Chase Spenser Coffman, Daniel Benjamin Dadon, Lisa Liu, Sadiqua Shadbar, Chaitanya Sudrik, Yi Tang, Shankul Vartak
  • Patent number: 11077059
    Abstract: The invention provides methods for the preparation of particles including one or more agents, e.g., therapeutic or diagnostic agents. The particles can be formed by creating droplets of a first liquid, e.g., including an agent, and removing the first liquid, e.g., through its dispersal in a second liquid and/or evaporation, to solidify the droplets. Advantageously, the process of forming the particles does not significantly alter the structure or activity of the agents and may enhance the stability of the agents. For example, the particles may be stored for long periods of time without significant loss of activity, and in some embodiments, without the need for refrigeration. These particles may be used to generate stabilized pharmaceutical compositions for storage or other logistical purposes, pharmaceutical suspensions, pharmaceutical powder formulations (e.g., inhalable powders, injectable powders), creams or other topical pastes, nutraceuticals, or cosmetics.
    Type: Grant
    Filed: July 25, 2018
    Date of Patent: August 3, 2021
    Assignee: Elektrofi, Inc.
    Inventors: Chase Spenser Coffman, Lyndon Fitzgerald Charles, Jr., Paul Brown, Daniel Benjamin Dadon, Lisa Liu, Cory Robinson, Dale Arlington Thomas, III